ORTEC INTERNATIONAL INC
10-Q, EX-27, 2000-11-13
MEDICAL LABORATORIES
Previous: ORTEC INTERNATIONAL INC, 10-Q, 2000-11-13
Next: SECTOR STRATEGY FUND V LP, 10-Q, 2000-11-13



<TABLE> <S> <C>

<ARTICLE>                  5

<S>                                    <C>
<PERIOD-TYPE>                                9-MOS
<FISCAL-YEAR-END>                      DEC-31-2000
<PERIOD-START>                         JAN-01-2000
<PERIOD-END>                           SEP-30-2000
<CASH>                                  13,097,056
<SECURITIES>                                     0
<RECEIVABLES>                                    0
<ALLOWANCES>                                     0
<INVENTORY>                                      0
<CURRENT-ASSETS>                        13,190,279
<PP&E>                                   3,818,188
<DEPRECIATION>                           2,052,599
<TOTAL-ASSETS>                          15,532,897
<CURRENT-LIABILITIES>                    1,958,602
<BONDS>                                          0
<COMMON>                                 9,691,608
                            0
                                      0
<OTHER-SE>                                       0
<TOTAL-LIABILITY-AND-EQUITY>            15,532,897
<SALES>                                          0
<TOTAL-REVENUES>                           103,810
<CGS>                                            0
<TOTAL-COSTS>                            3,511,907
<OTHER-EXPENSES>                                 0
<LOSS-PROVISION>                        (3,408,097)
<INTEREST-EXPENSE>                               0
<INCOME-PRETAX>                                  0
<INCOME-TAX>                                     0
<INCOME-CONTINUING>                              0
<DISCONTINUED>                                   0
<EXTRAORDINARY>                                  0
<CHANGES>                                        0
<NET-INCOME>                            (3,408,097)
<EPS-BASIC>                                 (.38)
<EPS-DILUTED>                                 (.38)


















© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission